IFN-α, -β, and -γ are able to directly upregulate the expression of surface tumor-associated antigens (75, 76) via augmentation of MHC I class and MHC II class molecules (77), thus increasing the immunogenicity of tumor cells and making them more vulnerable to identification and subsequent destruction by the immune system. Here, IFNA2 is linked to neoplasm.